# US 2022/0016061 A1 · Preparation Stabilized by Means of Nonaqueous Solvent

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2022/0016061 A1
- Document ID: US20220016061A1
- Status: Published application
- Kind: A1
- Application number: 17/281,824
- Filed: 2019-10-04
- Published: 2022-01-20
- Earliest claimed: 2018-10-04
- Assignees: Medrx Co., Ltd.
- Applicants: MEDRx Co., Ltd.
- Inventors: Jun Nakamura; Yasushi Miwa; Keiko Yamasaki; Hidetoshi Hamamoto
- Web page: https://patentgrep.com/patent/US20220016061A1

## CPC

- A61K 9/0014: {Skin, i.e. galenical aspects of topical compositions (non-active ingredients are additionally classified in A61K47/00; A61K9/0009, A61K9/0021, A61K9/7015, A61K9/7023 take precedence; cosmetic preparations A61K8/00, A61Q; preparations for wound dressings or bandages A61L26/00)}
- A61K 31/197: the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid (carnitine A61K31/205)
- A61K 9/08: Solutions {(composition of solutions A61K47/00)}
- A61K 9/7053: {obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene}
- A61K 9/7061: {Polyacrylates}
- A61K 9/7084: {Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches}
- A61K 47/12: Carboxylic acids; Salts or anhydrides thereof
- A61K 47/20: containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
- A61P 25/08: Antiepileptics; Anticonvulsants
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The present invention provides a composition for external application comprising baclofen or a salt thereof, specifically baclofen hydrochloride with high transdermal absorbability and stability, and a method of stabilizing a preparation comprising baclofen or a salt thereof.

## Claims

### Claim 1

A composition for external application comprising baclofen hydrochloride and DMSO.

### Claim 2

(canceled)

### Claim 3 (depends on 1)

The composition for external application according to claim 1, which further comprises one or more C16-20 fatty acids.

### Claim 4 (depends on 3)

The composition for external application according to claim 3, wherein the C16-20 fatty acid is oleic acid, isostearic acid or a mixture thereof.

### Claim 5 (depends on 1)

A patch preparation comprising a support and an adhesive layer laminated on one side of the support, wherein the adhesive layer comprises the composition for external application according to claim 1.

### Claim 6 (depends on 1)

A patch preparation comprising:
(a) a solvent-impermeable first sheet;
(b) a solvent-impermeable second sheet attached to an upper surface of the first sheet, forming a non-sealing region and a sealing region surrounding the non-sealing region with the first sheet, and having a cutting part formed to annularly extend along an outer circumferential edge of the non-sealing region;
(c) a transdermal absorption preparation carrying member carrying the composition for external application according to claim 1 disposed between the first sheet and the second sheet in the non-sealing region and fixed to the second sheet inside the cutting part; and
(d) an adhesive third sheet attached in a removable manner to an upper surface of the second sheet.

### Claim 7

A method of stabilizing a preparation comprising baclofen or a salt thereof, which comprises dissolving baclofen hydrochloride in an organic solvent and/or an inorganic solvent.

### Claim 8 (depends on 7)

The method according to claim 7, wherein the organic solvent comprises DMSO.
